Unsupervised genome-wide variant effect predictor based on pretraining of DNA language models

The Genomic Pre-trained Network (GPN), a multispecies model developed to learn genome-wide variant effects.

Markey and Manchin urge FDA to stop its study of opioids for chronic pain

Two Democratic senators are warning the Food and Drug Administration not to proceed with a controversial trial meant to measure opioids’ effectiveness as a chronic

September 22, 2023

Sanofi and Regeneron debut next generation in Dupixent’s asthma campaign

The leading TV ad-spending drug brand is getting a campaign refresh for one of its indications. Sanofi and Regeneron renewed the effort for Dupixent in

April 30, 2024

High cardiorespiratory fitness may protect against 9 types of cancer in men

Good cardiorespiratory fitness when young is associated with up to a 40% lower risk of developing 9 specific cancers later on-; at least in men-;

August 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.